Syngene International shares slump 10% after Q4 profit dips despite revenue growth

Posted by on



Syngene Q4 profit dips 3% YoY to Rs 183 crore; stock falls 10%.
Revenue rises 11% YoY to Rs 1,018 crore; EBITDA up 8.4%.
US biologics facility acquisition boosts CDMO presence, says CEO.
Price target Rs 844, implying 24% upside; stock down 23% YTD.

Comments

Post a Comment